Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 31-Oct-24
Select bar for recommendation details.
Recommendations | 31-Oct-24 | |
---|---|---|
Buy | 2 | |
Outperform | 4 | |
Hold | 5 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Hikma Pharmaceuticals Plc have a median target of 2,194.86, with a high estimate of 2,743.57 and a low estimate of 1,994.97. The median estimate represents a 18.26% increase from the last price of 1,856.00.
High | 47.8% | 2,743.57 |
Med | 18.3% | 2,194.86 |
Low | 7.5% | 1,994.97 |
Dividends in USD
Div growth (TTM) | 30.11% |
---|
More ▼
Earnings history & estimates in USD
Average growth rate | +10.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | +6.99% |
More ▼